135 related articles for article (PubMed ID: 1650361)
1. Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships.
Tan A; van den Broek L; van Boeckel S; Ploegh H; Bolscher J
J Biol Chem; 1991 Aug; 266(22):14504-10. PubMed ID: 1650361
[TBL] [Abstract][Full Text] [Related]
2. Introduction of oxygen into the alkyl chain of N-decyl-dNM decreases lipophilicity and results in increased retention of glucose residues on N-linked oligosaccharides.
Tan A; van den Broek L; Bolscher J; Vermaas DJ; Pastoors L; van Boeckel C; Ploegh H
Glycobiology; 1994 Apr; 4(2):141-9. PubMed ID: 8054714
[TBL] [Abstract][Full Text] [Related]
3. Characterization of calf liver glucosidase I and its inhibition by basic sugar analogs.
Schweden J; Borgmann C; Legler G; Bause E
Arch Biochem Biophys; 1986 Jul; 248(1):335-40. PubMed ID: 2942110
[TBL] [Abstract][Full Text] [Related]
4. Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein.
Gross V; Tran-Thi TA; Schwarz RT; Elbein AD; Decker K; Heinrich PC
Biochem J; 1986 Jun; 236(3):853-60. PubMed ID: 2947571
[TBL] [Abstract][Full Text] [Related]
5. Effects of the glucosidase inhibitors nojirimycin and deoxynojirimycin on the biosynthesis of membrane and secretory glycoproteins.
Peyrieras N; Bause E; Legler G; Vasilov R; Claesson L; Peterson P; Ploegh H
EMBO J; 1983; 2(6):823-32. PubMed ID: 6227481
[TBL] [Abstract][Full Text] [Related]
6. Purification by affinity chromatography of glucosidase I, an endoplasmic reticulum hydrolase involved in the processing of asparagine-linked oligosaccharides.
Hettkamp H; Legler G; Bause E
Eur J Biochem; 1984 Jul; 142(1):85-90. PubMed ID: 6235111
[TBL] [Abstract][Full Text] [Related]
7. Demonstration that Golgi endo-alpha-D-mannosidase provides a glucosidase-independent pathway for the formation of complex N-linked oligosaccharides of glycoproteins.
Moore SE; Spiro RG
J Biol Chem; 1990 Aug; 265(22):13104-12. PubMed ID: 2165493
[TBL] [Abstract][Full Text] [Related]
8. Role of endoplasmic reticular calcium in oligosaccharide processing of alpha 1-antitrypsin.
Kuznetsov G; Brostrom MA; Brostrom CO
J Biol Chem; 1993 Jan; 268(3):2001-8. PubMed ID: 8380585
[TBL] [Abstract][Full Text] [Related]
9. A vesicular intermediate in the transport of hepatoma secretory proteins from the rough endoplasmic reticulum to the Golgi complex.
Lodish HF; Kong N; Hirani S; Rasmussen J
J Cell Biol; 1987 Feb; 104(2):221-30. PubMed ID: 3027103
[TBL] [Abstract][Full Text] [Related]
10. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
Fenouillet E; Gluckman JC
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of N-linked oligosaccharide processing does not prevent the secretion of thyroglobulin. A study with swainsonine and deoxynojirimycin.
Franc JL; Hovsepian S; Fayet G; Bouchilloux S
Eur J Biochem; 1986 May; 157(1):225-32. PubMed ID: 2940087
[TBL] [Abstract][Full Text] [Related]
12. Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the Golgi complex.
Lodish HF; Kong N
J Cell Biol; 1984 May; 98(5):1720-9. PubMed ID: 6233287
[TBL] [Abstract][Full Text] [Related]
13. Rapid and reversible inhibition of tyrosinase activity by glucosidase inhibitors in human melanoma cells.
Takahashi H; Parsons PG
J Invest Dermatol; 1992 Apr; 98(4):481-7. PubMed ID: 1532183
[TBL] [Abstract][Full Text] [Related]
14. Comparison between 1-deoxynojirimycin and N-methyl-1-deoxynojirimycin as inhibitors of oligosaccharide processing in intestinal epithelial cells.
Romero PA; Saunier B; Herscovics A
Biochem J; 1985 Mar; 226(3):733-40. PubMed ID: 3157369
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of myoblast fusion by the glucosidase inhibitor N-methyl-1-deoxynojirimycin, but not by the mannosidase inhibitor 1-deoxymannojirimycin.
Holland PC; Herscovics A
Biochem J; 1986 Sep; 238(2):335-40. PubMed ID: 2948497
[TBL] [Abstract][Full Text] [Related]
16. N-methyl-N-(5-carboxypentyl)-1-deoxynojirimycin, a new affinity ligand for the purification of trimming glucosidase I.
Bause E; Gross A; Schweden J
FEBS Lett; 1991 Jan; 278(2):167-70. PubMed ID: 1825064
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-hydroxyethyl-1-deoxynojirimycin (BAY m 1099) on the activity of neutral- and acid alpha-glucosidases in human fibroblasts and HepG2 cells.
Wisselaar HA; van Dongen JM; Reuser AJ
Clin Chim Acta; 1989 Jun; 182(1):41-52. PubMed ID: 2546700
[TBL] [Abstract][Full Text] [Related]
18. 1-deoxynojirimycin impairs oligosaccharide processing of alpha 1-proteinase inhibitor and inhibits its secretion in primary cultures of rat hepatocytes.
Gross V; Andus T; Tran-Thi TA; Schwarz RT; Decker K; Heinrich PC
J Biol Chem; 1983 Oct; 258(20):12203-9. PubMed ID: 6226656
[TBL] [Abstract][Full Text] [Related]
19. Activation of lipoprotein lipase in cardiac myocytes by glycosylation requires trimming of glucose residues in the endoplasmic reticulum.
Carroll R; Ben-Zeev O; Doolittle MH; Severson DL
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):693-6. PubMed ID: 1497606
[TBL] [Abstract][Full Text] [Related]
20. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.
Asano N; Nishida M; Kato A; Kizu H; Matsui K; Shimada Y; Itoh T; Baba M; Watson AA; Nash RJ; Lilley PM; Watkin DJ; Fleet GW
J Med Chem; 1998 Jul; 41(14):2565-71. PubMed ID: 9651160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
